Ultrasound assessment of cervical length in first pregnancies past 41 weeks can serve as an independent predictor of the likelihood of spontaneous labor and successful vaginal delivery. Cervical length was shorter in women who experienced spontaneous onset of labor.
Ultrasound assessment of cervical length in first pregnancies past 41 weeks can serve as an independent predictor of the likelihood of spontaneous labor and successful vaginal delivery. Cervical length was shorter in women who experienced spontaneous onset of labor.
Dr. P. Vankayalapati and colleagues in the fetal medicine unit at St. George's Hospital in London published their study in Ultrasound in Obstetrics and Gynecology, which made it available online Feb. 8.
They worked with women up to 41 + three weeks of pregnancy who presented at a dedicated clinic for postdate pregnancies. Patients were examined with transvaginal ultrasound to assess cervical length, and results were recorded until the progress and outcome of the pregnancy was known. Those who reached 42 weeks without delivery were given the option of induced labor.
Researchers also tracked which patients delivered vaginally versus cesarean section and compared these data with the sonographic cervical length measurements.
The 112 women in the study who began labor spontaneously had a significantly shorter cervical length, with a mean measurement of 25 mm. The 67 women in the study who had labor induced had a mean cervical length of 28.7 mm.
Statistical analysis showed that for women who hadn't given birth before, cervical length was an independent predictor of spontaneous labor leading to vaginal delivery. For those who had given birth before, statistical analysis showed cervical length to be a predictor of vaginal delivery but not necessarily of spontaneous labor.
The researchers concluded that transvaginal ultrasound could be used to differentiate which women with postdated pregnancies would need to be induced and to predict the likilood of cesarean section.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.